{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T10:45:04Z","timestamp":1774867504384,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1124\/jpet.103.060525","type":"journal-article","created":{"date-parts":[[2004,4,22]],"date-time":"2004-04-22T00:29:43Z","timestamp":1082593783000},"page":"650-660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Effects of N-Substituted Analogs of Benztropine: Diminished Cocaine-Like Effects in Dopamine Transporter Ligands"],"prefix":"10.1016","volume":"309","author":[{"given":"Jonathan L.","family":"Katz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa A.","family":"Kopajtic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory E.","family":"Agoston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy Hauck","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.103.060525_bib1","doi-asserted-by":"crossref","unstructured":"Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, and Newman AH (1997) N-Substituted 3-[bis(4\u2032-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter. J Med Chem 40: 4329-4339.","DOI":"10.1021\/jm970525a"},{"key":"10.1124\/jpet.103.060525_bib2","unstructured":"Campbell VC, Kopajtic TA, Newman AH, and Katz JL (2002) Evaluation of interactions between histamine H1 antagonist and cocaine effects as a mechanism for the decreased cocaine-like effects of benztropine analogs; Abstracts of the 32nd Annual Meeting of the Society for Neuroscience; 2002 Nov 2\u20137; Orlando, FL, Program No. 806.11 2002 Abstract Viewer\/Itinerary Planner. Online. Society for Neuroscience, Washington, DC."},{"key":"10.1124\/jpet.103.060525_bib3","doi-asserted-by":"crossref","unstructured":"Carlton P and Didamo P (1961) Augmentation of the behavioral effects of amphetamine by atropine. J Pharmacol Exp Ther 132: 91-96.","DOI":"10.1016\/S0022-3565(25)26012-8"},{"key":"10.1124\/jpet.103.060525_bib4","doi-asserted-by":"crossref","unstructured":"Carroll FI, Kotian P, Dehghani A, Gray JL, Kuzemko MA, Parham KA, Abraham P, Lewin AH, Boja JW, and Kuhar MJ (1995) Cocaine and 3\u03b2-(4\u2032-substituted phenyl)tropane-2\u03b2-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter. J Med Chem 38: 379-388.","DOI":"10.1021\/jm00002a020"},{"key":"10.1124\/jpet.103.060525_bib5","doi-asserted-by":"crossref","unstructured":"Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108.","DOI":"10.1016\/0006-2952(73)90196-2"},{"key":"10.1124\/jpet.103.060525_bib6","unstructured":"Finney DJ (1964) Statistical Method in Biological Assay, 2nd ed. Hafner, New York."},{"key":"10.1124\/jpet.103.060525_bib7","doi-asserted-by":"crossref","unstructured":"Fleckenstein AE, Kopajtic TA, Boja JW, Carroll FI, and Kuhar MJ (1996) Highly potent cocaine analogs cause long-lasting increases in locomotor activity. Eur J Pharm 311: 109-114.","DOI":"10.1016\/0014-2999(96)00423-2"},{"key":"10.1124\/jpet.103.060525_bib8","doi-asserted-by":"crossref","unstructured":"Holtzman SG (2001) Differential interaction of GBR12909, a dopamine uptake inhibitor, with cocaine and methamphetamine in rats discriminating cocaine. Psychopharmacology 155: 180-186.","DOI":"10.1007\/s002130100684"},{"key":"10.1124\/jpet.103.060525_bib9","doi-asserted-by":"crossref","unstructured":"Katz JL, Agoston GE, Alling KL, Kline RH, Forster MJ, Woolverton WL, Kopajtic TA, and Newman AH (2001) Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents. Psychopharmacology 154: 362-374.","DOI":"10.1007\/s002130000667"},{"key":"10.1124\/jpet.103.060525_bib10","doi-asserted-by":"crossref","unstructured":"Katz JL, Izenwasser S, Kline RH, Allen AC, and Newman AH (1999) Novel 3\u03b1-diphenylmethoxy-tropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine. J Pharmacol Exp Ther 288: 302-315.","DOI":"10.1016\/S0022-3565(24)37956-X"},{"key":"10.1124\/jpet.103.060525_bib11","doi-asserted-by":"crossref","unstructured":"Katz JL, Libby TA, Kopajtic T, Husbands SM, and Newman AH (2003) Behavioral effects of rimcazole analogues alone and in combination with cocaine. Eur J Pharmacol 468: 109-119.","DOI":"10.1016\/S0014-2999(03)01638-8"},{"key":"10.1124\/jpet.103.060525_bib12","doi-asserted-by":"crossref","unstructured":"Kimmel HL, Carroll FI, and Kuhar MJ (2001) Locomotor stimulant effects of novel phenyltropanes in the mouse. Drug Alcohol Depend 65: 25-36.","DOI":"10.1016\/S0376-8716(01)00144-2"},{"key":"10.1124\/jpet.103.060525_bib13","doi-asserted-by":"crossref","unstructured":"Kline RH, Izenwasser S, Katz JL, Joseph DB, Bowen WD, and Newman AH (1997) 3\u2032-Chloro-3\u03b1-(diphenylmethoxy)tropane but not 4\u2032-chloro-3\u03b1-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile. J Med Chem 40: 851-857.","DOI":"10.1021\/jm950782k"},{"key":"10.1124\/jpet.103.060525_bib14","doi-asserted-by":"crossref","unstructured":"Kuhar MJ, Ritz MC, and Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14: 299-302.","DOI":"10.1016\/0166-2236(91)90141-G"},{"key":"10.1124\/jpet.103.060525_bib15","doi-asserted-by":"crossref","unstructured":"Matsumoto RR, McCracken KA, Pouw B, Miller J, Bowen WD, Williams W, and de Costa BR (2001) N-Alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice. Eur J Pharmacol 411: 261-273.","DOI":"10.1016\/S0014-2999(00)00917-1"},{"key":"10.1124\/jpet.103.060525_bib16","unstructured":"MDS Panlabs Pharmacology Services (2000) Pharmacology Services Catalogue. MDS Panlabs, Bothell, WA."},{"key":"10.1124\/jpet.103.060525_bib17","doi-asserted-by":"crossref","unstructured":"Menkel M, Terry P, Pontecorvo M, Katz JL, and Witkin JM (1991) Selective sigma ligands block stimulant effects of cocaine. Eur J Pharmacol 201: 251-252.","DOI":"10.1016\/0014-2999(91)90355-T"},{"key":"10.1124\/jpet.103.060525_bib18","doi-asserted-by":"crossref","unstructured":"Newman AH, Allen AC, Izenwasser S, and Katz JL (1994) Novel 3\u03b1-(diphenylmethoxy)tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles. J Med Chem 37: 2258-2261.","DOI":"10.1021\/jm00041a002"},{"key":"10.1124\/jpet.103.060525_bib19","doi-asserted-by":"crossref","unstructured":"Newman AH, Kline RH, Allen AC, Izenwasser S, George C, and Katz JL (1995) Novel 4\u2032- and 4\u2032,4\u2032\u2032-disubstituted-3\u03b1-(diphenylmethoxy)tropane analogues as potent and selective dopamine uptake inhibitors. J Med Chem 38: 3933-3940.","DOI":"10.1021\/jm00020a006"},{"key":"10.1124\/jpet.103.060525_bib20","doi-asserted-by":"crossref","unstructured":"Newman AH and Kulkarni SS (2002) Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic - a focus on analogues of benztropine and rimcazole. Med Res Rev 22: 429-464.","DOI":"10.1002\/med.10014"},{"key":"10.1124\/jpet.103.060525_bib21","doi-asserted-by":"crossref","unstructured":"Raje S, Cao J, Newman AH, Gao H, and Eddington ND (2003) Evaluation of the blood-brain barrier transport, population pharmacokinetics and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques. J Pharmacol Exp Ther 307: 801-808.","DOI":"10.1124\/jpet.103.053504"},{"key":"10.1124\/jpet.103.060525_bib22","doi-asserted-by":"crossref","unstructured":"Ranaldi R and Woolverton WL (2002) Self administration of cocaine: scopolamine combinations by rhesus monkeys. Psychopharmacology 161: 442-448.","DOI":"10.1007\/s00213-002-1069-3"},{"key":"10.1124\/jpet.103.060525_bib23","unstructured":"Richelson E (1981) Tricyclic antidepressants: interactions with histamine and muscarinic cholinergic receptors, in Antidepressants: Neurochemical, Behavioral and Clinical Perspectives (Enna SJ, Malick JB, and Richelson E eds) pp 53-73, Raven Press, New York."},{"key":"10.1124\/jpet.103.060525_bib24","doi-asserted-by":"crossref","unstructured":"Romieu P, Martin-Fardon R, and Maurice T (2000) Involvement of the sigma1 receptor in the cocaine-induced conditioned place preference. Neuroreport 11: 2885-2888.","DOI":"10.1097\/00001756-200009110-00011"},{"key":"10.1124\/jpet.103.060525_bib25","doi-asserted-by":"crossref","unstructured":"Scheckel C and Boff E (1964) Behavioral effects of interacting imipramine and other drugs with d-amphetamine, cocaine and tetrabenazine. Psychopharmacologia 5: 198-206.","DOI":"10.1007\/BF00413242"},{"key":"10.1124\/jpet.103.060525_bib26","unstructured":"Snedecor GW and Cochran WG (1967) Statistical Methods, 6th ed. Iowa State College, Ames, IA."},{"key":"10.1124\/jpet.103.060525_bib27","doi-asserted-by":"crossref","unstructured":"Spealman RD, Goldberg SR, Kelleher RT, Morse WH, Goldberg DM, Hakansson CG, Nieforth KA, and Lazar ES (1979) Effects of norcocaine and some norcocaine derivatives on schedule-controlled behavior of pigeons and squirrel monkeys. J Pharmacol Exp Ther 10: 196-205.","DOI":"10.1016\/S0022-3565(25)31732-5"},{"key":"10.1124\/jpet.103.060525_bib28","doi-asserted-by":"crossref","unstructured":"Spealman RD, Goldberg SR, Kelleher RT, Goldberg DM, and Charlton JP (1977) Some effects of cocaine and two cocaine analogs on schedule-controlled behavior of squirrel monkeys. J Pharmacol Exp Ther 202: 500-509.","DOI":"10.1016\/S0022-3565(25)30986-9"},{"key":"10.1124\/jpet.103.060525_bib29","unstructured":"Stevens JP (1990) Intermediate Statistics: A Modern Approach. Lawrence Erlbaum Associates, Hillsdale, NJ."},{"key":"10.1124\/jpet.103.060525_bib30","doi-asserted-by":"crossref","unstructured":"Tolliver BK, Newman AH, Katz JL, Ho LB, Fox LM, Hsu K Jr, and Berger SP (1999) Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo. J Pharmacol Exp Ther 289: 110-122.","DOI":"10.1016\/S0022-3565(24)38113-3"},{"key":"10.1124\/jpet.103.060525_bib31","doi-asserted-by":"crossref","unstructured":"Wilson MC and Schuster CR (1973) Cholinergic influence on intravenous cocaine self-administration by rhesus monkeys. Pharmacol Biochem Behav 1: 643-649.","DOI":"10.1016\/0091-3057(73)90027-0"},{"key":"10.1124\/jpet.103.060525_bib32","doi-asserted-by":"crossref","unstructured":"Woolverton WL, Hecht GS, Agoston GE, Katz JL, and Newman AH (2001) Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys. Psychopharmacology 154: 375-382.","DOI":"10.1007\/s002130000616"},{"key":"10.1124\/jpet.103.060525_bib33","doi-asserted-by":"crossref","unstructured":"Woolverton WL, Rowlett JK, Wilcox KM, Paul IA, Kline RH, Newman AH, and Katz JL (2000) 3\u2032 and 4\u2032-Chloro-substituted analogs of benztropine: intravenous self-administration and in vitro radioligand binding studies in rhesus monkeys. Psychopharmacology 147: 426-435.","DOI":"10.1007\/s002130050012"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524313254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524313254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.103.060525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:52:27Z","timestamp":1739998347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524313254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0022356524313254"],"URL":"https:\/\/doi.org\/10.1124\/jpet.103.060525","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of N-Substituted Analogs of Benztropine: Diminished Cocaine-Like Effects in Dopamine Transporter Ligands","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.103.060525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}